GF
Gates Foundation Portfolio holdings
AUM
$43.5M
This Quarter Return
-16.03%
1 Year Return
+14.19%
3 Year Return
-58.08%
5 Year Return
–
10 Year Return
–
AUM
$342M
AUM Growth
+$342M
(-48%)
Cap. Flow
-$280M
Cap. Flow
% of AUM
-81.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
LMDX
LumiraDx Limited Common Shares
LMDX
|
$46.1M |
| 2 |
Sera Prognostics
SERA
|
$8.7M |
Top Sells
| 1 |
BioNTech
BNTX
|
$243M |
| 2 |
Vir Biotechnology
VIR
|
$91.4M |
Sector Composition
| 1 | Healthcare | 98.83% |
| 2 | Materials | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
CureVac
CVAC
$1.21B
| $171M | 50.12% | 3,134,780 | – | – |
|
|
LMDX
2
DELISTED
LumiraDx Limited Common Shares
LMDX
| $46.1M | 13.5% | +5,574,059 | New | +$46.1M |
|
|
3
BioNTech
BNTX
$24B
| $40.6M | 11.89% | 148,674 -890,000 | -86% | -$243M |
|
|
4
Vir Biotechnology
VIR
$686M
| $29.5M | 8.64% | 677,777 -2,100,000 | -76% | -$91.4M |
|
5
Immunocore
IMCR
$1.62B
| $21.4M | 6.26% | 576,923 | – | – |
|
6
Butterfly Network
BFLY
$405M
| $10.6M | 3.1% | 1,011,003 | – | – |
|
|
7
Sera Prognostics
SERA
$123M
| $8.7M | 2.55% | +779,814 | New | +$8.7M |
|
|
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $8.7M | 2.55% | 1,396,644 | – | – |
|
|
AMRS
9
DELISTED
Amyris Inc.
AMRS
| $4M | 1.17% | 292,398 | – | – |
|
|
ZY
10
DELISTED
Zymergen Inc. Common Stock
ZY
| $800K | 0.23% | 59,970 | – | – |
|